Jump to content

Jiban Jyoti Panda

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by PrimeBOT (talk | contribs) at 20:18, 16 February 2023 (top: Task 30: deprecated parameter removal from Template:infobox scientist). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Jiban Jyoti Panda
Born
Citizenship
  • India (by birth)
Alma mater
Awards
Scientific career
FieldsBiotechnology, Nano-technology
Institutions

Dr. Jiban Jyoti Panda is an Indian scientist specializing in the field of nano-biotechnology. She has been awarded numerous awards in recognition for her work including the UNESCO - L`Oreal For Women in Science Fellowship,[1] [2] [3] which recognizes the achievements of exceptional women across the globe.

Education

[edit]

Dr. Jyoti Panda started her education by enrolling at Utkal University in the state of Odisha in India. She completed her Bachelor of Science (Honours) in chemistry, zoology and botany in 2003. She subsequently completed her Master of Science degree in the field of biotechnology from the same university in 2005. Later, she went on to complete a Ph.D. in biotechnology at the International Centre for Genetic Engineering and Biotechnology, India, in 2012.[4]

Research

[edit]

Her primary interests are in the field of Nano-biotechnology. She works on the design and synthesis of novel bio-compatible and multi-functional nano-structures for achieving targeted and effective drug delivery to different organs especially the organs like brain and eye, which are protected by different physiological barriers and are inaccessible to drugs administered via the oral and parenteral routes.[5] She also designs bio-compatible drug delivery systems for effective cancer therapy.[6] [7][8]

Developing novel methods for effective blood brain barrier delivery for treating glioblastomas and other neurodegenerative disorders as well as developing and characterizing different drug nano-formulations with enhanced activity are also her main focus of research. She has published numerous papers in peer reviewed journals.[9]

Publications

[edit]
  • Dube T, Mandal S, Panda JJ. Nanoparticles generated from a tryptophan derivative: physical characterization and anti-cancer drug delivery. Amino Acids. 2017 Mar 10. doi: 10.1007/s00726-017-2403-8. [Epub ahead of print]
  • Alam S, Panda JJ, Mukherjee TK, Chauhan VS. Short peptide based nanotubes capable of effective curcumin delivery for treating drug resistant malaria. J Nanobiotechnology. 2016 Apr 5;14:26.
  • Panda JJ, Yandrapu S, Kadam RS, Chauhan VS, Kompella UB. Retracted: Self-assembled Phenylalanine-α,β-dehydrophenylalanine Nanotubes for Sustained Intravitreal Delivery of a Multi-targeted Tyrosine Kinase Inhibitor. J Control Release. 2016 Sep 10;237:186. doi: 10.1016/j.jconrel.2016.07.039.
  • Panda JJ, Mishra J. Self-assembled dipeptide-based nanostructures: tiny tots with great applications. Ther Deliv. 2016;7(2):59-62. doi: 10.4155/tde.15.85. Epub 2016 Jan 15.
  • Panda JJ, Chauhan VS. Short Peptide Based Self-Assembled Nanostructures: Implication In Drug Delivery And Tissue Engineering. Polymer Chemistry, under review.
  • Sofi Beaula W, Gowri M, Panda JJ, Rajeswari K, Venkateshbabu N, Rabel, AM, Kandaswamy D, Chauhan VS and Ganesh.V. European Journal of Dentistry, accepted.
  • Panda JJ, Yandrapu, S, Kadam, RS, Chauhan, VS, and Kompella, UB. Self-assembled phenylalanine-α,β-dehydrophenylalanine nanotubes for 2 sustained intravitreal delivery of a multi-targeted tyrosine kinase inhibitor. Journal of Controlled Release, 2013, 172(3):1151-60.
  • Panda JJ, Varsheney A and Chauhan VS. Self-assembled nanoparticles based on modified cationic dipeptides and DNA: novel systems for gene delivery. Journal of Nanobiotechnology, 2013, 11:18.
  • Panda JJ, Kaul A, Kumar S, Alam S, Mishra AK, Kundu, GC, Chauhan, VS. Modified dipeptide nanoparticles: vehicles for tumor targeted delivery. Nanomedicine, 2013, 8, 1927-1942.
  • Alam S, *Panda JJ, Chauhan VS. Novel dipeptide nanoparticles for effective curcumin delivery. International Journal of Nanomedicine, 2012:7 4207–4222.*Both the authors have equal contribution.
  • Panda JJ, Dua R, Mishra A, Mittra B, Chauhan VS. 3D cell growth and proliferation on a RGD functionalized nanofibrillar hydrogel based on a conformationally restricted residue containing dipeptide. Acs Applied Materials and Interfaces, 2010, 2, 2839-48.
  • Panda JJ, Mishra A, Basu A, Chauhan VS. Stimuli responsive self-assembled hydrogel of a low molecular weight free dipeptide with potential for tunable drug delivery. Biomacromolecules (2008), 9(8): 2244–2250.
  • Panda JJ, Kaul A, Alam S, Babbar AK, Mishra AK, Chauhan VS. Designed peptides as model self-assembling nanosystems: characterization and potential biomedical applications. Therapeutic delivery, 2011.
  • Mishra A, Panda JJ, Basu A, Chauhan VS. Nanovesicles based on self-assembly of conformationally constrained aromatic residue containing amphiphilic dipeptides. Langmuir (2008), 24(9): 4571-4576.
  • Rout GR, Senapati SK, Panda JJ. Selection of salt tolerant plants of Nicotiana tabacum L. through in vitro and its biochemical characterization. Acta Biol Hung. 2008 Mar; 59(1):77-92.
  • Sahoo SK, Parveen S, Panda JJ. The present and future of nanotechnology in human health care. Journal of Nanomedicine: Nanotechnology, Biology and Medicine. (2007), 3(1): 20-31. IF: 8. Number one in the top 25 hottest article of the journal.

References

[edit]
  1. ^ "2011 Fellowships | United Nations Educational, Scientific and Cultural Organization". Archived from the original on 2016-08-22. Retrieved 2016-11-10.
  2. ^ "UNESCO-L'OREAL International Fellowships in Life Sciences - 2011" (PDF). UNESCO. 3 November 2010. Archived from the original (PDF) on 2016-11-10. Retrieved 2016-11-10.
  3. ^ "Jyoti Jiban Panda- Latest News on Jyoti Jiban Panda | Read Breaking News on Zee News". Archived from the original on 2016-11-10. Retrieved 2016-11-10.
  4. ^ "Institute of Nano Science and Technology". Archived from the original on 2016-11-10. Retrieved 2016-11-10.
  5. ^ "Treating brain tumour with a nanotech-based drug delivery system". 26 May 2011. Archived from the original on 10 November 2016. Retrieved 10 November 2016.
  6. ^ "'Science Academies' Lecture Workshop on "Emerging Technologies based on Nanoscience- A popularization workshop"" (PDF). Mody University. 22–23 April 2016. Archived (PDF) from the original on 25 November 2016. Retrieved 10 November 2016.
  7. ^ "Archived copy". Archived from the original on 2016-11-10. Retrieved 2016-11-10.{{cite web}}: CS1 maint: archived copy as title (link)
  8. ^ Panda, Jiban J.; Kaul, Ankur; Kumar, Santosh; Alam, Shadab; Mishra, Anil K.; Kundu, Gopal C.; Chauhan, Virander S. (2013). "Modified dipeptide-based nanoparticles: Vehicles for targeted tumor drug delivery". Nanomedicine. 8 (12): 1927–1942. doi:10.2217/nnm.12.201. PMID 23398497.
  9. ^ "Profile: Jiban Panda". ResearchGate. Archived from the original on 2022-06-03. Retrieved 2022-06-03.